Trial Profile
Early results of the first Brazilian patients with generalised congenital lipodystrophy on treatment with metreleptin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2017
Price :
$35
*
At a glance
- Drugs Metreleptin (Primary)
- Indications Lipodystrophy
- Focus Therapeutic Use
- 06 Oct 2017 New trial record
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes